LONGO, MIRIAM
 Distribuzione geografica
Continente #
NA - Nord America 428
EU - Europa 368
AS - Asia 81
AF - Africa 2
OC - Oceania 1
Totale 880
Nazione #
US - Stati Uniti d'America 428
IE - Irlanda 189
IT - Italia 81
DE - Germania 62
SG - Singapore 38
CN - Cina 19
FI - Finlandia 10
KR - Corea 9
CZ - Repubblica Ceca 8
TR - Turchia 5
BE - Belgio 4
CH - Svizzera 3
GB - Regno Unito 3
HK - Hong Kong 3
IN - India 3
IR - Iran 3
NL - Olanda 3
FR - Francia 2
SE - Svezia 2
AU - Australia 1
DZ - Algeria 1
EG - Egitto 1
GR - Grecia 1
KG - Kirghizistan 1
Totale 880
Città #
Dublin 188
Chandler 110
Santa Clara 64
Munich 30
New York 25
Singapore 24
Bremen 20
Ashburn 19
Princeton 17
Roxbury 17
Cambridge 16
Beijing 11
Naples 11
Seoul 9
Brno 7
Marigliano 7
Boardman 6
Lappeenranta 6
Cagliari 5
Istanbul 5
Los Angeles 5
Brussels 4
Castel Campagnano 4
Formia 4
Helsinki 4
San Gennaro Vesuviano 4
Turin 4
Boydton 3
Calitri 3
Lugano 3
Napoli 3
North Charleston 3
Pune 3
Amsterdam 2
Aversa 2
Castel Volturno 2
Forlì 2
Fossano 2
San Nicola la Strada 2
Sant'Arpino 2
Avellino 1
Bari 1
Bishkek 1
Borås 1
Brdo 1
Cairo 1
Caivano 1
Capua 1
Cardito 1
Changsha 1
Clonee 1
Des Moines 1
Giugliano in Campania 1
Grottaminarda 1
Hanover 1
Hong Kong 1
Jiaxing 1
Lamezia Terme 1
Langweer 1
Medford 1
Nuremberg 1
Piedimonte d'Alife 1
Policoro 1
Sassari 1
Seattle 1
Stockholm 1
Sydney 1
Totale 685
Nome #
Change in circulating levels of endothelial progenitor cells and sexual function in women with type 1 diabetes 66
Applications for social security benefits related to diabetes in the working age in Italy between 2009 and 2019: a nationwide retrospective cohort study 51
Impact of pituitary autoimmunity and genetic disorders on growth hormone deficiency in children and adults 46
Simplification of complex insulin therapy: a story of dogma and therapeutic resignation 43
Sodium-glucose co-transporter-2 inhibitors for the prevention of cardiorenal outcomes in type 2 diabetes: An updated meta-analysis 39
GLP-1 receptor agonists and cardiorenal outcomes in type 2 diabetes: an updated meta-analysis of eight CVOTs 38
Glycemic Control and the Heart: The Tale of Diabetic Cardiomyopathy Continues 38
Improvement of glycemic control and reduction of major cardiovascular events in 18 cardiovascular outcome trials: an updated meta-regression 37
Exploring the performance of ultrasound risk stratification systems in thyroid nodules of pediatric patients 37
Renal and metabolic effects of SGLT-2i and DPP-4i according to basal estimated glomerular filtration rate: Analysis from GIOIA, an observational prospective study 37
When amputation is not the end of the challenge: A successful therapy for osteomyelitis and soft tissue infection in a patient with type 1 diabetes 37
Mediterranean diet in type 2 diabetes: An updated overview of pharmacological activities of cardiometabolic and reproductive outcomes 37
GLP-1 receptor agonists vs. SGLT-2 inhibitors: the gap seems to be leveling off 35
The effect of DPP-4 inhibitors, GLP-1 receptor agonists and SGLT-2 inhibitors on cardiorenal outcomes: a network meta-analysis of 23 CVOTs 35
Varicocele: An Endocrinological Perspective 35
Hypothalamic-Pituitary Autoimmunity and Related Impairment of Hormone Secretions in Chronic Fatigue Syndrome 34
SGLT-2 inhibitors and cardiorenal outcomes in patients with or without type 2 diabetes: a meta-analysis of 11 CVOTs 34
Neuroimmunoendocrinology of SARS-CoV 2 Infection 33
Feasibility of simplification from a basal-bolus insulin regimen to a fixed-ratio formulation of basal insulin plus a glp-1ra or to basal insulin plus an SGLT2 inhibitor: BEYOND, a randomized, pragmatic trial 30
European Safety Analysis of mRNA and Viral Vector COVID-19 Vaccines on Glucose Metabolism Events 26
Repeat thyroid FNAC: Inter-observer agreement among high- and low-volume centers in Naples metropolitan area and correlation with the EU-TIRADS 24
Reply to the letter to the editor by Mungmunpuntipantip et al 24
Assessment of Neuroendocrine Changes and Hypothalamo-Pituitary Autoimmunity in Patients with COVID-19 23
Glucose control during breakthrough SARS-CoV-2 infections in vaccinated patients with type 1 diabetes 18
Circulating levels of endothelial progenitor cells are associated with better cognitive function in older adults with glucagon-like peptide 1 receptor agonist-treated type 2 diabetes 15
Signs of a Glucose and Insulin-Independent Gut-Bone Axis and Aberrant Bone Homeostasis in Type 1 Diabetes 15
Liraglutide for Lower Limb Perfusion in People With Type 2 Diabetes and Peripheral Artery Disease: The STARDUST Randomized Clinical Trial 10
Telemedicine for type 2 diabetes during COVID-19 pandemic: experience from a tertiary diabetes center 10
Two years with GIOIA 'Effects of gliflozins and gliptins on markers of cardiovascular damage in type 2 diabetes': A prospective, multicentre, quasi-experimental study on sodium-glucose cotransporter 2 and dipeptidyl peptidase-4 inhibitors in diabetes clinical practice 9
BEYOND 2 years: durability of metabolic benefits by simplification of complex insulin regimens in type 2 diabetes 7
Sleep quality and glucose control in adults with type 1 diabetes during the seasonal daylight saving time shifts 6
Prevalence and Management of Complications of Percutaneous Ethanol Injection for Cystic Thyroid Nodules: A Systematic Review of Literature and Meta-analysis 6
Totale 935
Categoria #
all - tutte 5.857
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.857


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203 0 0 0 0 0 0 0 0 0 0 2 1
2020/202112 7 0 0 0 3 0 1 0 0 0 1 0
2021/202295 0 0 0 0 2 0 4 3 11 18 4 53
2022/2023428 46 6 9 25 72 27 0 26 194 7 6 10
2023/2024236 24 8 10 23 53 45 14 2 4 9 11 33
2024/2025161 12 14 19 13 103 0 0 0 0 0 0 0
Totale 935